Digestive System Disease

Analysis of clinical feature of 11 cases of very early-onset inflammatory bowel disease

  • Xinguo ZHENG ,
  • Hui YANG
Expand
  • Department of gastroenterology, Nanjing Children's Hospital, Nanjing 210000, Jiangsu, China

Received date: 2023-01-31

  Online published: 2023-11-08

Abstract

Objective To explore and analyze the clinical characteristics, genetic diagnosis results, treatment, and prognosis of children with very early onset inflammatory bowel disease (VEO-IBD) in China. Methods A retrospective analysis was conducted on the clinical data of VEO-IBD patients admitted and confirmed from January 2017 to October 2022. Results There were 11 children with VEO-IBD, including 6 males and 5 females; Among them, there were 8 cases of Krohn's disease, 1 case of ulcerative colitis, and 2 cases of undifferentiated inflammatory bowel disease. The median age of onset was16(6-29) months. The main clinical symptoms were diarrhea (63.6%), bloody stools (100%), and abdominal pain (45.5%). Five patients had perianal lesions, and two had intestinal stenosis. Among the 6 VEO-IBD patients who completed gene testing, 2 had genetic mutations, specifically mutations in the NOD2 and IL10RA genes. Conclusions The clinical manifestations of VEO-IBD are mainly diarrhea, abdominal pain, and bloody stool, which are easy to be associated with perianal diseases and have poor treatment prognosis especially for children with single gene variation. Single gene mutation detection should be carried out in children with VEO-IBD, and individual treatment measures should be implemented at anearly stage.

Cite this article

Xinguo ZHENG , Hui YANG . Analysis of clinical feature of 11 cases of very early-onset inflammatory bowel disease[J]. Journal of Clinical Pediatrics, 2023 , 41(11) : 815 -819 . DOI: 10.12372/jcp.2023.23e0031

References

[1] Uhlig HH, Schwerd T, Koletzko S, et al. The diagnostic approach to monogenic very early onset inflammatory bowel disease[J]. Gastroenterology, 2014, 147(5): 990-1007.
[2] Shim JO. Recent advance in very early onset inflammatory bowel disease[J]. Pediatr Gastroenterol Hepatol Nutr, 2019, 22(1): 41-49.
[3] 中华医学会儿科学分会消化学组, 中华医学会儿科学分会临床营养学组. 儿童炎症性肠病诊断和治疗专家共识[J]. 中华儿科杂志, 2019, 57(7): 501-507.
[4] WHO Multicenter Growth Reference Study Group. WHO child growth standards: length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age[S]. Geneva: WHO, 2006.
[5] de Onis M, Onyango AW, Borghi E, et al. Development of a WHO growth reference for school-aged children and adolescents[J]. Bull World Health Organ, 2007, 85(9): 660-667.
[6] Arie Levine, Sibylle Koletzko, Dan Turner, 等. 欧洲儿科胃肠病学、肝病学和营养协会儿童及青少年炎症性肠病诊断的改良波尔图标准(2014年版)[J]. 中华儿科杂志, 2016, 54(10): 728-732.
[7] Kuenzig ME, Fung SG, Marderfeld L, et al. Twenty-first century trends in the global epidemiology of pediatric-onset inflammatory bowel disease: systematic review[J]. Gastroenterology, 2022, 162(4): 1147-1159.
[8] Ghione S, Sarter H, Fumery M, et al. Dramatic increase in incidence of ulcerative colitis and Crohn's disease (1988-2011): a population-based study of French adolescents[J]. Am J Gastroenterol, 2018, 113(2): 265-272.
[9] Wang XQ, Zhang Y, Xu CD, et al. Inflammatory bowel disease in Chinese children: a multicenter analysis over a decade from Shanghai[J]. Inflam Bowel Dis, 2013, 19(2): 423-428.
[10] Benchimol EI, Bernstein CN, Bitton A, et al. Trends in epidemiology of pediatric inflammatory bowel disease in Canada: distributed network analysis of multiple population- based provincial health administrative databases[J]. Am J Gastroenterol, 2017, 112(7): 1120-1134.
[11] Xiao Y, Wang XQ, Yu Y, et al. Comprehensive mutation screening for 10 genes in Chinese patients suffering very early onset inflammatory bowel disease[J]. World J Gastroenterol, 2016, 22(24): 5578-5588.
[12] Huang Z, Peng K, Li X, et al. Mutations in interleukin-10 receptor and clinical phenotypes in patients with very early onset inflammatory bowel disease: a Chinese VEO-IBD collaboration group survey[J]. Inflamm Bowel Dis, 2017, 23(4): 578-590.
[13] Garber A, Regueiro M. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, etio-pathogenesis, and management[J]. Curr Gastroenterol Rep, 2019, 21(7): 31.
[14] Kelsen JR, Sullivan KE, Rabizadeh S, et al. North American society for pediatric gastroenterology, hepatology, and nutrition position paper on the evaluation and management for patients with very early-onset inflammatory bowel disease[J]. J Pediatr Gastroenterol Nutr, 2020, 70(3): 389-403.
[15] Dong F, Xiao F, Ge T, et al. Case report: a novel compound heterozygous mutation in IL-10RA in a Chinese child with very early-onset inflammatory bowel disease[J]. Front Pediatr, 2021, 9: 678390.
[16] Abbott DW, Wilkins A, Asara JM, et al. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO[J]. Curr Biol, 2004, 14(24): 2217-2227.
Outlines

/